More biosimilars reach the market in efforts to improve access and cut costs

被引:0
|
作者
Abraham, Jame
机构
来源
关键词
D O I
10.12788/jcso.0417
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E181 / E184
页数:4
相关论文
共 50 条
  • [1] Biosimilars and market access: a question of comparability and costs?
    Simoens, Steven
    Verbeken, Gilbert
    Huys, Isabelle
    TARGETED ONCOLOGY, 2012, 7 (04) : 227 - 231
  • [2] Biosimilars and market access: a question of comparability and costs?
    Steven Simoens
    Gilbert Verbeken
    Isabelle Huys
    Targeted Oncology, 2012, 7 : 227 - 231
  • [3] Joint efforts cut heat costs
    Anon
    Gas world, 1988, 193 (4836):
  • [4] Market access of biosimilars: not only a cost issue
    Simoens, S.
    Verbeken, G.
    Huys, I.
    ONCOLOGIE, 2011, 13 (05) : 218 - 221
  • [5] A health economic guide to market access of biosimilars
    Simoens, Steven
    Vulto, Arnold G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (01) : 9 - 17
  • [6] Cut costs or improve reliability?
    PPI Pulp Pap Int, 2009, 4 (27):
  • [7] BIOSIMILARS: MARKET ACCESS AND MARKET PENETRATION - A COMPARISON OF FRANCE AND GERMANY
    Freiberg, M.
    Schwarz, R.
    Khoury, C.
    VALUE IN HEALTH, 2016, 19 (07) : A442 - A442
  • [8] Biosimilars in Belgium: a proposal for a more competitive market
    Moorkens, Evelien
    Vulto, Arnold G.
    Huys, Isabelle
    ACTA CLINICA BELGICA, 2021, 76 (06) : 441 - 452
  • [9] ROLE OF BUDGET IMPACT ANALYSIS IN MARKET ACCESS OF BIOSIMILARS
    Singh, A.
    Jha, R. K.
    Mazumder, D.
    Kapoor, A.
    VALUE IN HEALTH, 2015, 18 (07) : A529 - A529
  • [10] MOTOROLA STEPS UP QUALITY EFFORTS TO CUT COSTS
    FINLAY, D
    COMPUTER DESIGN, 1990, 29 (18): : 6 - 6